Ticker

So-Young International (NASDAQ: SY) used its fourth-quarter and full-year 2025 earnings call to outline what management described as a "strategic turning point" for 2026, as the company continues to scale its branded aesthetic center network while shifting focus toward improved profitability and operating efficiency. Industry backdrop and strategic focus Founder, Chairman, and CEO Xing Jin said

So-Young International Inc. (SY) Q4 2025 Earnings Call Transcript

BEIJING, March 25, 2026 /PRNewswire/ -- So-Young International Inc. (Nasdaq: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenues were RMB460.7 million…

BEIJING, March 10, 2026 /PRNewswire/ -- So-Young International Inc. (NASDAQ: SY) ("So-Young" or the "Company"), the leading aesthetic treatment platform in China connecting consumers with online services and offline treatments, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, before U.S. markets open on March 25, 2026. So-Young's management will…

CVS Health (NYSE: CVS - Get Free Report) and So-Young International (NASDAQ: SY - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, risk, valuation, analyst recommendations, institutional ownership and dividends. Volatility and Risk CVS Health has a beta